NCT03600649 2023-11-21
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas
Salarius Pharmaceuticals, LLC
Phase 1 Unknown
Salarius Pharmaceuticals, LLC
Central European Society for Anticancer Drug Research
Jiangsu Simcere Pharmaceutical Co., Ltd.
National Center for Research Resources (NCRR)